Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US IPO, aims to raise up to 100 million dollars
智通财经2026/09/21 07:11Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Securities Times APP has learned that TRex Bio, a biotechnology company specializing in the development of drugs for autoimmune and inflammatory diseases, filed with the U.S. Securities and Exchange Commission (SEC) last Friday to raise up to 100 million U.S. dollars through its initial public offering (IPO).
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Novo Nordisk plans to expand oral GLP-1 production capacity by 10 times by 2030
智通财经•2026/09/21 08:31
Crypto prices
More
Bitcoin
BTC
$82,177.78
+2.28%
Ethereum
ETH
$2,681.14
+4.04%
Tether USDt
USDT
$0.9997
+0.01%
BNB
BNB
$773.76
+3.29%
XRP
XRP
$1.45
+4.95%
USDC
USDC
$0.9998
-0.00%
Solana
SOL
$113.45
+4.80%
TRON
TRX
$0.3433
+0.50%
Zcash
ZEC
$1,506.17
+4.41%
Hyperliquid
HYPE
$94.68
+4.35%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now